Literature DB >> 7708746

Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity.

E L Hohmann1, C A Oletta, W P Loomis, S I Miller.   

Abstract

Attenuated Salmonella are useful oral vaccine vectors capable of carrying multiple heterologous antigen genes, but optimal expression of foreign antigens has not yet been achieved. We hypothesized that Salmonella phoP-activated genes, which are transcriptionally activated within antigen-processing macrophages, could prove useful for delivery of heterologous antigens to the immune system. We have created a suicide vector that allows the stable chromosomal insertion of heterologous antigen genes within the phoP-activated gene C (pagC) of Salmonella and permits the expression of heterologous antigens as fusion proteins between the first 84 amino acids of PagC and the chosen antigen. The Escherichia coli phoA gene encoding alkaline phosphatase was cloned into this vector; the resultant plasmid was used to construct Salmonella typhimurium strains that express PagC-alkaline phosphatase fusion proteins from a single chromosomal gene copy. Such strains were administered orally and i.p. as vaccines to BALB/c mice and compared with control strains expressing alkaline phosphatase constitutively. After 3 weeks, mouse sera were analyzed for IgG responses to S. typhimurium lipopolysaccharide and alkaline phosphatase. Remarkably, though all mice had comparable antibody responses to lipopolysaccharide, only mice immunized with strains bearing phoP-activated fusion genes had antibody responses to the heterologous antigen. We conclude that expression of a heterologous antigen from an S. typhimurium in vivo-induced promoter that is activated within macrophages markedly enhances the immunogenicity of a model antigen expressed from a single chromosomal gene copy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7708746      PMCID: PMC42327          DOI: 10.1073/pnas.92.7.2904

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon.

Authors:  I C Blomfield; V Vaughn; R F Rest; B I Eisenstein
Journal:  Mol Microbiol       Date:  1991-06       Impact factor: 3.501

2.  Selection of bacterial virulence genes that are specifically induced in host tissues.

Authors:  M J Mahan; J M Slauch; J J Mekalanos
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

3.  Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses.

Authors:  G F Su; H N Brahmbhatt; J Wehland; M Rohde; K N Timmis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Construction of delta aroA his delta pur strains of Salmonella typhi.

Authors:  M F Edwards; B A Stocker
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

5.  A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells.

Authors:  I Behlau; S I Miller
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

6.  Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci.

Authors:  W J Belden; S I Miller
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine.

Authors:  S N Chatfield; I G Charles; A J Makoff; M D Oxer; G Dougan; D Pickard; D Slater; N F Fairweather
Journal:  Biotechnology (N Y)       Date:  1992-08

8.  Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

Authors:  C Gonzalez; D Hone; F R Noriega; C O Tacket; J R Davis; G Losonsky; J P Nataro; S Hoffman; A Malik; E Nardin; M B Sztein; D G Heppner; T R Fouts; A Isibasi; M M Levine
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

9.  Analysis of proteins synthesized by Salmonella typhimurium during growth within a host macrophage.

Authors:  K Z Abshire; F C Neidhardt
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

10.  Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors.

Authors:  L Cárdenas; J D Clements
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

View more
  28 in total

1.  The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival.

Authors:  A B Blanc-Potard; E A Groisman
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 2.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

Review 3.  New technologies in using recombinant attenuated Salmonella vaccine vectors.

Authors:  Roy Curtiss; Wei Xin; Yuhua Li; Wei Kong; Soo-Young Wanda; Bronwyn Gunn; Shifeng Wang
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

4.  IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice.

Authors:  Samia M Al-Ojali; C B Tara Moore; Maria J Fernandez-Cabezudo; Basel K Al-Ramadi
Journal:  Med Microbiol Immunol       Date:  2012-06-10       Impact factor: 3.402

5.  Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.

Authors:  Shifeng Wang; Yuhua Li; Huoying Shi; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

6.  Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.

Authors:  Heinz Arnold; Dirk Bumann; Melanie Felies; Britta Gewecke; Meike Sörensen; J Engelbert Gessner; Joachim Freihorst; Bernd Ulrich von Specht; Ulrich Baumann
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi.

Authors:  Jason B Harris; Andrea Baresch-Bernal; Sean M Rollins; Ashfaqul Alam; Regina C LaRocque; Margaret Bikowski; Amanda F Peppercorn; Martin Handfield; Jeffery D Hillman; Firdausi Qadri; Stephen B Calderwood; Elizabeth Hohmann; Robert F Breiman; W Abdullah Brooks; Edward T Ryan
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

8.  Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters.

Authors:  S J McSorley; D Xu; F Y Liew
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

9.  Autodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains.

Authors:  Konstantin Rizos; Claus T Lattemann; Dirk Bumann; Thomas F Meyer; Toni Aebischer
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium.

Authors:  David Baud; Jalil Benyacoub; Véronique Revaz; Menno Kok; Françoise Ponci; Martine Bobst; Roy Curtiss; Pierre De Grandi; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.